Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 5
1986 1
1989 2
1990 4
1991 1
1992 1
1996 1
2000 1
2015 1
2019 1
2021 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis.
Li T, Zhu Y, Fan S, Liu X, Xu H, Liang Y. Li T, et al. Med Mycol. 2015 Jun;53(5):455-61. doi: 10.1093/mmy/myv017. Epub 2015 Apr 15. Med Mycol. 2015. PMID: 25877666 Clinical Trial.
Terconazole is a new, broad-spectrum, triazole antifungal agent. The aim of this study was to compare the efficacy and safety of a 6-day course of a terconazole vaginal suppository (80 mg) with two doses of oral fluconazole (150 mg) for the treatment of severe vulvo …
Terconazole is a new, broad-spectrum, triazole antifungal agent. The aim of this study was to compare the efficacy and safety of a 6- …
Use of Novasomes as a Vesicular Carrier for Improving the Topical Delivery of Terconazole: In Vitro Characterization, In Vivo Assessment and Exploratory Clinical Experimentation.
Mosallam S, Ragaie MH, Moftah NH, Elshafeey AH, Abdelbary AA. Mosallam S, et al. Int J Nanomedicine. 2021 Jan 8;16:119-132. doi: 10.2147/IJN.S287383. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33447031 Free PMC article. Clinical Trial.
PURPOSE: This manuscript aimed at encapsulating an antifungal terconazole (TCZ) into innovative novasomes for improving its penetration into the skin and clinically modulating its therapeutic efficacy. ...
PURPOSE: This manuscript aimed at encapsulating an antifungal terconazole (TCZ) into innovative novasomes for improving its penetrati …
Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis.
Kjaeldgaard A. Kjaeldgaard A. Pharmatherapeutica. 1986;4(8):525-31. Pharmatherapeutica. 1986. PMID: 3520601 Clinical Trial.
Three comparable groups were treated with 200 mg clotrimazole or 80 mg terconazole vaginal tablets once daily for 3 consecutive days, or one 240 mg terconazole vaginal tablet followed by 2 identical placebo pessaries. ...It was concluded that terconazole repr …
Three comparable groups were treated with 200 mg clotrimazole or 80 mg terconazole vaginal tablets once daily for 3 consecutive days, …
Terconazole and miconazole cream for treating vulvovaginal candidiasis. A comparison.
Corson SL, Kapikian RR, Nehring R. Corson SL, et al. J Reprod Med. 1991 Aug;36(8):561-7. J Reprod Med. 1991. PMID: 1941796 Clinical Trial.
In a double-blind, randomized, multicenter study, 900 patients diagnosed with vulvovaginal candidiasis received either 0.4% (307 patients) or 0.8% (299 patients) terconazole cream or 2.0% miconazole nitrate cream (294 patients). After seven days of treatment the combined m …
In a double-blind, randomized, multicenter study, 900 patients diagnosed with vulvovaginal candidiasis received either 0.4% (307 patients) o …
Clinical evaluation of terconazole. United states experience.
Thomason JL. Thomason JL. J Reprod Med. 1989 Aug;34(8 Suppl):597-601. J Reprod Med. 1989. PMID: 2677365 Clinical Trial.
Recently, results of short- and long-term analyses in the United States confirmed the efficacy and safety of 0.4% terconazole cream and 80-mg terconazole suppositories. In short-term evaluations (eight to ten days after therapy), 0.4% terconazole cream was as …
Recently, results of short- and long-term analyses in the United States confirmed the efficacy and safety of 0.4% terconazole cream a …
Prevention of recurrent vaginal candidiasis with weekly terconazole cream.
Stein GE, Mummaw NL, Schooley SL. Stein GE, et al. Ann Pharmacother. 1996 Oct;30(10):1080-3. doi: 10.1177/106002809603001002. Ann Pharmacother. 1996. PMID: 8893111 Clinical Trial.
OBJECTIVE: To investigate the prophylactic use of weekly terconazole 0.8% cream to prevent recurrent episodes of candidal vaginitis. DESIGN: Women with a documented history of recurrent candidal vaginitis (> or = 4 recurrences/y) were enrolled into a secondary preventio …
OBJECTIVE: To investigate the prophylactic use of weekly terconazole 0.8% cream to prevent recurrent episodes of candidal vaginitis. …
Comparison of 0.8% and 1.6% terconazole cream in severe vulvovaginal candidiasis.
Schmitt C, Sobel J, Meriwether C. Schmitt C, et al. Obstet Gynecol. 1990 Sep;76(3 Pt 1):414-6. Obstet Gynecol. 1990. PMID: 2381618 Clinical Trial.
Terconazole is the first topical triazole antifungal agent. The results of several European clinical trials have shown both terconazole cream and suppositories to be effective and safe in the treatment of vulvovaginal candidiasis. ...This study confirms the efficacy …
Terconazole is the first topical triazole antifungal agent. The results of several European clinical trials have shown both tercon …
Terconazole for the treatment of vulvovaginal candidiasis.
Thomason JL, Gelbart SM, Kellett AV, Scaglione NJ, Gotwalt KT, Broekhuizen FF. Thomason JL, et al. J Reprod Med. 1990 Nov;35(11):992-4. J Reprod Med. 1990. PMID: 2277372 Clinical Trial.
A double-blind, randomized trial was conducted to evaluate the efficacy and safety of terconazole for vulvovaginal candidiasis. Treatment consisted of daily intravaginal application of one of the following regimens: 80-mg terconazole suppositories for 3 days, micona …
A double-blind, randomized trial was conducted to evaluate the efficacy and safety of terconazole for vulvovaginal candidiasis. Treat …
Efficacy of ketoconazole gel-flakes in treatment of vaginal candidiasis: Formulation, in vitro and clinical evaluation.
Abd Ellah NH, Abdel-Aleem JA, Abdo MN, Abou-Ghadir OF, Zahran KM, Hetta HF. Abd Ellah NH, et al. Int J Pharm. 2019 Aug 15;567:118472. doi: 10.1016/j.ijpharm.2019.118472. Epub 2019 Jun 25. Int J Pharm. 2019. PMID: 31252146 Clinical Trial.
Despite reduced dosage regimen (50 mg/daily/three days), KTZ flakes in situ gel was as effective as Gynoconazol vaginal cream (80 mg terconazole/daily/three days) in improving patient complaints and Candida eradication. Multifunctionality of KTZ carrier was based on effici …
Despite reduced dosage regimen (50 mg/daily/three days), KTZ flakes in situ gel was as effective as Gynoconazol vaginal cream (80 mg terc …
20 results